Sexually Transmissible Infections and Prostate Cancer Risk
- 1 September 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (9), 2374-2381
- https://doi.org/10.1158/1055-9965.epi-08-0173
Abstract
Background: Sexually transmissible infections (STI) have been variably associated with increased risks of prostate cancer, largely in case-control studies. Methods: In the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, we examined risk of prostate cancer in relation to serum antibodies to Chlamydia trachomatis, human papillomavirus-16 and -18, herpes simplex virus-2, cytomegalovirus, and human herpesvirus-8 in 868 cases (765 Whites and 103 Blacks) and 1,283 controls matched by race, age, time since initial screening, and year of blood draw; all blood samples were collected at least 1 year before prostate cancer diagnosis, except for 43 Black cases. We also assessed risk associated with self-reported history of syphilis and gonorrhea. Results: Prevalences of the 7 STIs among controls were weakly correlated, and all were more frequent among Blacks than Whites, except for human herpesvirus-8. Among Whites, prostate cancer risk was not significantly associated with the individual infections or with their number (Ptrend = 0.1); however, men with one or more STI had slightly higher risk (odds ratio, 1.3; 95% confidence interval, 1.0-1.6). Among Blacks, excess risk was associated with IgA antibody to C. trachomatis (odds ratio, 2.1; 95% confidence interval, 1.2-3.6). Conclusion: This large prospective study of prostate cancer shows no consistent association with specific STIs and a borderline association with any versus none. Whether a shared response or correlated infection not directly measured underlies the weak association requires further study. (Cancer Epidemiol Biomarkers Prev 2008;17(9):2374–81)Keywords
This publication has 72 references indexed in Scilit:
- Acne and risk of prostate cancerInternational Journal of Cancer, 2007
- Plasma Antibodies against Chlamydia trachomatis, Human Papillomavirus, and Human Herpesvirus Type 8 in Relation to Prostate Cancer: A Prospective StudyCancer Epidemiology, Biomarkers & Prevention, 2007
- No link between viral findings in the prostate and subsequent cancer developmentBritish Journal of Cancer, 2006
- Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactorsInternational Journal of Cancer, 2006
- Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL VariantPLoS Pathogens, 2006
- Methods for etiologic and early marker investigations in the PLCO trialMutation Research, 2005
- Sexual Transmission and the Natural History of Human Herpesvirus 8 InfectionNew England Journal of Medicine, 1998
- Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis?The Lancet, 1998
- Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white malesThe Prostate, 1996
- Immune response of prostatic cancer patients to cytomegalovirus-infected and -transformed human cellsCancer, 1978